Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

SHE/300981 stock hub

SHE/300981 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300981is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.3B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300981

In the news

Latest news · SHE/300981

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/En/a

P25 23.5P50 41.3P75 83.2

ROE-2.4

P25 -0.9P50 4.1P75 8.8

ROIC-1.4

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300981 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

200

Groups with data

Currency

CNY

Showing 200 of 200 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	4,228
Employees Change	-124%
Employees Change Percent	-2.85
Enterprise value	CNY 4.2B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	CNE100004KR0
Last refreshed	2026-05-10
Market cap	CNY 6.3B
Price	CNY 14.77
Price currency	CNY
Rev Per Employee	554,866.58x
Sector	Healthcare
Sic	3842
Symbol	she/300981
Website	https://www.zhonghongmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2%
EV Earnings	-33.25x
EV/EBITDA	24.22x
EV/FCF	-31.95x
EV/Sales	1.79x
FCF yield	-2.08%
P/B ratio	1.17x
P/S ratio	2.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-2.08%
EBITDA Margin	7.18%
Gross margin	11.27%
Gross Profit	CNY 264.5M
Gross Profit Growth	-24.97%
Gross Profit Growth Q	2.43%
Gross Profit Growth5 Y	-44.44%
Net Income	CNY -126.4M
Net Income Growth Q	-73.94%
Net Income Growth Years	0%
Pretax Margin	-6.02%
Profit Margin	-5.39%
Profit Per Employee	CNY -29,890
ROA	-0.4
Roa5y	5.49
ROCE	-0.88
ROE	-2.36
Roe5y	9.35
ROIC	-1.43
Roic5y	26.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	37.59%
Cagr3y	1.62%
Cagr5y	-18.27%
Div CAGR3	-26.76%
EPS Growth Q	-74.04
EPS Growth Years	0
OCF Growth	-47.1%
OCF Growth3 Y	37.82%
OCF Growth5 Y	-54.05%
Revenue Growth	-7.67x
Revenue Growth Q	-4.33x
Revenue Growth Years	0x
Revenue Growth3 Y	17.9x
Revenue Growth5 Y	-18.98x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.31
Assets	CNY 7.8B
Cash	CNY 3.9B
Current Assets	CNY 5.1B
Current Liabilities	CNY 2.2B
Debt	CNY 1.6B
Debt EBITDA	CNY 9.36
Debt Equity	CNY 0.3
Debt FCF	CNY -12.35
Equity	CNY 5.4B
Liabilities	CNY 2.4B
Long Term Assets	CNY 2.6B
Long Term Liabilities	CNY 158.5M
Net Cash	CNY 2.3B
Net Cash By Market Cap	CNY 35.98
Net Cash Growth	33.03%
Net Debt EBITDA	CNY -13.48
Net Debt Equity	CNY -0.42
Tangible Book Value	CNY 5B
Tangible Book Value Per Share	CNY 11.73
WACC	5.71

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.32
Inventory Turnover	3.02
Net Working Capital	CNY 525.1M
Quick ratio	1.95
Working Capital	CNY 2.9B
Working Capital Turnover	CNY 0.73

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.58%
Dividend Growth	-45%
Dividend Growth Years	0%
Dividend per share	CNY 0.23
Dividend Years	5
Dividend Yield	1.54%
Ex Div Date	2025-06-27
Last Dividend	CNY 0.25
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	37.56%
200-day SMA	13.85
3Y total return	4.95%
50-day SMA	14
50-day SMA vs 200-day SMA	50over200
5Y total return	-63.53%
All Time High	62.08
All Time High Change	-76.21%
All Time High Date	2021-04-27
All Time Low	7.56
All Time Low Change	95.5%
All Time Low Date	2024-02-06
ATR	0.72
Beta	0.53
Beta1y	-0.03
Beta2y	0.46
Ch YTD	17.6
High	14.99
High52	18.87
High52 Date	2025-08-12
High52ch	-21.73%
Low	14.68
Low52	10.84
Low52 Date	2025-05-08
Low52ch	36.31%
Ma50ch	5.51%
Price vs 200-day SMA	6.62%
RSI	54.7
RSI Monthly	53.84
RSI Weekly	55.65
Sharpe ratio	0.95x
Sortino ratio	1.88
Total Return	2.12%
Tr YTD	17.6
Tr1m	-4.52%
Tr1w	-1.53%
Tr3m	13.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY -48.9M
Operating Income Growth Q	53.57
Operating margin	-2.08

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	117,024,068%
Net Borrowing	606,692,790
Shares Insiders	11.46%
Shares Institutions	0.99%
Shares Out	427,428,757
Shares Qo Q	-4.53%
Shares Yo Y	-0.58%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY -131.5M
Average Volume	14,168,331.5x
Bv Per Share	12.26
CAPEX	CNY -205.1M
Ch1m	-4.52
Ch1w	-1.53
Ch1y	34.95
Ch3m	13.88
Ch3y	-4.99
Ch5y	-69.51
Ch6m	10.14
Change	-0.2%
Change From Open	-0.2
Close	14.8
Days Gap	0
Depreciation Amortization	217,396,183
Dollar Volume	75,540,589
Earnings Date	2026-04-27
EBIT	CNY -48.9M
EBITDA	CNY 168.5M
EPS	CNY -0.29
F Score	3
FCF	CNY -131.5M
FCF EV Yield	-3.13x
FCF Per Share	CNY -0.31
Financing CF	477,245,274
Fiscal Year End	December
Founded	2,010
Goodwill	90,921,625
Income Tax	CNY -10.6M
Investing CF	165,153,437
Is Primary Listing	1
Last Earnings Date	2026-04-27
Last Report Date	2026-03-31
Last Split Date	2025-06-27
Last Split Type	Forward
Ma150	13.69
Ma150ch	7.87%
Ma20	14.31
Ma20ch	3.22%
Net CF	695,044,774
Next Earnings Date	2026-08-28
Open	14.8
P OCF Ratio	85.78
Payment Date	2025-06-27
Position In Range	29.03
Ppne	1,846,309,708
Price Date	2026-05-08
Price EBITDA	CNY 37.46
Ptbv Ratio	1.26
Relative Volume	0.36x
Revenue	2,345,975,884x
Tax By Revenue	-0.45x
Tr6m	10.14%
Volume	5,114,461

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300981 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.5%

$0.23 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+2.1%

Next ex-dividend date: 2025-06-27

Performance

SHE/300981 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300981?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.0%

Share of float held by funds and institutions

Insider ownership

+11.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.6%

Negative means the company is buying back shares.

Technical

SHE/300981 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.7

Neutral momentum band

Price vs 200-day MA

+6.6%

50/200-day relationship not available

Beta (5Y)

0.53

Less volatile than the market

Sharpe ratio

0.95

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300981

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300981 stock rating?

she/300981 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300981 analysis?

The full report lives at /stocks/she/300981/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300981?

The latest report frames she/300981 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300981 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.